K170181

Substantially Equivalent

Prizma

Applicant: G-Medical Innovations , Ltd.
Product code: DXH
Advisory panel: Cardiovascular
Date received: 2017-01-19
Decision date: 2017-09-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Rehovot, IL

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.